PLACEBO-CONTROLLED DOUBLE-BLIND TRIAL OF KETANSERIN IN TREATMENT OF INTERMITTENT CLAUDICATION
- 6 October 1984
- journal article
- clinical trial
- Published by Elsevier in The Lancet
- Vol. 324 (8406) , 775-779
- https://doi.org/10.1016/s0140-6736(84)90704-9
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Platelet-mediated vascular contractions: Inhibition of the serotonergic component by ketanserinThrombosis Research, 1982
- Treatment of hypertension with ketanserin, a new selective 5-HT2 receptor antagonist.BMJ, 1982
- Platelet activation during treadmill exercise in patients with chronic peripheral arterial diseaseThrombosis Research, 1981
- ACUTE BLOOD-PRESSURE-LOWERING EFFECT OF KETANSERINThe Lancet, 1981
- 5-HT2-RECEPTOR BLOCKADE IN THE TREATMENT OF HEART FAILUREThe Lancet, 1981
- Receptor binding profile of R 41 468, A novel antagonist at 5-HT2 receptorsLife Sciences, 1981
- Platelet Activation during Exercise-Induced Myocardial IschemiaNew England Journal of Medicine, 1980
- The Rheological Effects of Cinnarizine and Flunarizine in Normal and Pathologic ConditionsAngiology, 1979
- Improvement of the Flow Properties of Blood: a New Therapeutical Approach in Occlusive Arterial DiseaseAngiology, 1976
- IMPAIRED RED CELL DEFORMABILITY IN PERIPHERAL VASCULAR DISEASEThe Lancet, 1976